• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在蜂毒肽水凝胶中递送的经次氯酸处理的肿瘤细胞分泌物可增强癌症免疫疗法。

Secretions from hypochlorous acid-treated tumor cells delivered in a melittin hydrogel potentiate cancer immunotherapy.

作者信息

Zhou Yuhan, Ye Ting, Ye Chengzhi, Wan Chao, Yuan Siyue, Liu Yushuai, Li Tianyu, Jiang Fagang, Lovell Jonathan F, Jin Honglin, Chen Jing

机构信息

Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, PR China.

Department of Pediatrics, Renmin Hospital of Wuhan University, Wuhan, 430060, PR China.

出版信息

Bioact Mater. 2021 Jul 24;9:541-553. doi: 10.1016/j.bioactmat.2021.07.019. eCollection 2022 Mar.

DOI:10.1016/j.bioactmat.2021.07.019
PMID:34820587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8591392/
Abstract

Autologous tumor cells and cell-derived secretions (CDS) can induce antitumor immune responses. The conditions in which cells are cultured and treated impact CDS, and cellular insults alter their composition and function. In this study, we generated CDS from tumor cells exposed to normal culture conditions, hypoxia, cisplatin, radiotherapy, photodynamic therapy, or hypochlorous acid (HOCl). HOCl-CDS showed the strongest stimulatory effects on dendritic cells and macrophages compared to CDS generated by hypoxia, cisplatin, radiotherapy or photodynamic therapy. To improve HOCl-CDS activity at the tumor site, we loaded HOCl-CDS into a melittin-encapsulated hydrogel scaffold. When injected intratumorally, the HOCl-CDS hydrogel promoted tumor cell death, cytotoxic T lymphocyte infiltration, and tumor-associated macrophage reprogramming towards an M1 phenotype. The hydrogel inhibited tumor growth and prolonged the survival of mice bearing B16-F10 melanoma. Furthermore, hydrogel-delivered HOCl-CDS augmented the antitumor effects of immune checkpoint blockade. These results underscore the importance of the CDS generation method and delivery approach for improving cancer immunotherapy.

摘要

自体肿瘤细胞和细胞衍生分泌物(CDS)可诱导抗肿瘤免疫反应。细胞培养和处理的条件会影响CDS,而细胞损伤会改变其组成和功能。在本研究中,我们从暴露于正常培养条件、缺氧、顺铂、放疗、光动力疗法或次氯酸(HOCl)的肿瘤细胞中生成了CDS。与缺氧、顺铂、放疗或光动力疗法生成的CDS相比,HOCl-CDS对树突状细胞和巨噬细胞显示出最强的刺激作用。为了提高HOCl-CDS在肿瘤部位的活性,我们将HOCl-CDS加载到蜂毒肽包裹的水凝胶支架中。当瘤内注射时,HOCl-CDS水凝胶促进肿瘤细胞死亡、细胞毒性T淋巴细胞浸润以及肿瘤相关巨噬细胞重编程为M1表型。该水凝胶抑制肿瘤生长并延长携带B16-F10黑色素瘤小鼠的生存期。此外,水凝胶递送的HOCl-CDS增强了免疫检查点阻断的抗肿瘤作用。这些结果强调了CDS生成方法和递送方式对改善癌症免疫治疗的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/6fd484785682/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/56d731baeec3/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/dfeba5b86e18/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/15ab71cebf4c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/838ba73b45c3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/92e2795e8786/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/facfbdb7dc3d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/6fd484785682/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/56d731baeec3/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/dfeba5b86e18/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/15ab71cebf4c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/838ba73b45c3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/92e2795e8786/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/facfbdb7dc3d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86a8/8591392/6fd484785682/gr6.jpg

相似文献

1
Secretions from hypochlorous acid-treated tumor cells delivered in a melittin hydrogel potentiate cancer immunotherapy.在蜂毒肽水凝胶中递送的经次氯酸处理的肿瘤细胞分泌物可增强癌症免疫疗法。
Bioact Mater. 2021 Jul 24;9:541-553. doi: 10.1016/j.bioactmat.2021.07.019. eCollection 2022 Mar.
2
Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.靶向 CAMKII 重塑肿瘤相关巨噬细胞并抑制肿瘤细胞的可注射杂合肽水凝胶用于癌症免疫治疗。
Theranostics. 2020 Feb 10;10(7):3049-3063. doi: 10.7150/thno.42385. eCollection 2020.
3
Sustained release of tumor cell lysate and CpG from an injectable, cytotoxic hydrogel for melanoma immunotherapy.用于黑色素瘤免疫治疗的可注射细胞毒性水凝胶持续释放肿瘤细胞裂解物和CpG。
Nanoscale Adv. 2023 Mar 14;5(7):2071-2084. doi: 10.1039/d2na00911k. eCollection 2023 Mar 28.
4
A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside.用自体次氯酸氧化卵巢癌细胞裂解物冲击的树突状细胞疫苗可诱导有效的广谱抗肿瘤免疫:从基础到临床。
Clin Cancer Res. 2013 Sep 1;19(17):4801-15. doi: 10.1158/1078-0432.CCR-13-1185. Epub 2013 Jul 9.
5
Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.基于可注射多肽水凝胶的疫苗和免疫检查点抑制剂共递送提高了肿瘤免疫治疗效果。
Theranostics. 2019 Apr 12;9(8):2299-2314. doi: 10.7150/thno.30577. eCollection 2019.
6
Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic-Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy.载有蜂毒蜂肽和光敏剂的有机-无机杂化纳米载体的共递送用于光动力治疗和免疫治疗。
ACS Nano. 2019 Nov 26;13(11):12638-12652. doi: 10.1021/acsnano.9b04181. Epub 2019 Oct 22.
7
M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors.M1 巨噬细胞衍生的纳米囊泡增强免疫检查点抑制剂的抗癌疗效。
ACS Nano. 2018 Sep 25;12(9):8977-8993. doi: 10.1021/acsnano.8b02446. Epub 2018 Aug 29.
8
Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.Carboxyamidotriazole 与 IDO1-Kyn-AhR 通路抑制剂联合显著增强癌症免疫治疗。
J Immunother Cancer. 2019 Sep 11;7(1):246. doi: 10.1186/s40425-019-0725-7.
9
Immunogenic potential of three transmissible venereal tumor cell lysates to prime canine-dendritic cells for cancer immunotherapy.三种传染性性病肿瘤细胞裂解物对犬树突状细胞进行癌症免疫治疗的免疫原性潜力。
Res Vet Sci. 2018 Dec;121:23-30. doi: 10.1016/j.rvsc.2018.10.001. Epub 2018 Oct 5.
10
Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel.可注射肽水凝胶诱导肿瘤消融和治疗性免疫。
ACS Nano. 2018 Apr 24;12(4):3295-3310. doi: 10.1021/acsnano.7b08148. Epub 2018 Mar 22.

引用本文的文献

1
DCs pulsed with hypochlorous acid-treated tumor cell lysates present antigens efficiently and induce CD8 T cell activation through cross-presentation.用次氯酸处理的肿瘤细胞裂解物脉冲处理的树突状细胞能有效呈递抗原,并通过交叉呈递诱导CD8 T细胞活化。
Res Pharm Sci. 2025 Mar 31;20(2):230-240. doi: 10.4103/RPS.RPS_15_24. eCollection 2025 Apr.
2
Dietary advanced glycation end-products promote food allergy by disrupting intestinal barrier and enhancing Th2 immunity.膳食晚期糖基化终产物通过破坏肠道屏障和增强Th2免疫反应来促进食物过敏。
Nat Commun. 2025 May 28;16(1):4960. doi: 10.1038/s41467-025-60235-0.
3
Peptide hydrogel platform encapsulating manganese ions and high-density lipoprotein nanoparticle-mimicking nanovaccines for the prevention and treatment of gastric cancer.

本文引用的文献

1
Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity.多功能溶瘤纳米颗粒递送自我复制的 IL-12 RNA,以消除已建立的肿瘤并引发全身免疫。
Nat Cancer. 2020 Sep;1(9):882-893. doi: 10.1038/s43018-020-0095-6. Epub 2020 Aug 10.
2
Delivery Strategies for Melittin-Based Cancer Therapy.基于蜂毒素的癌症治疗的递药策略。
ACS Appl Mater Interfaces. 2021 Apr 21;13(15):17158-17173. doi: 10.1021/acsami.1c03640. Epub 2021 Apr 13.
3
Immunoregulatory Roles of Extracellular Vesicles and Associated Therapeutic Applications in Lung Cancer.
包裹锰离子和高密度脂蛋白纳米颗粒模拟纳米疫苗的肽水凝胶平台用于胃癌的预防和治疗。
J Transl Med. 2025 Mar 25;23(1):371. doi: 10.1186/s12967-025-06088-z.
4
Exosomes: a double-edged sword in cancer immunotherapy.外泌体:癌症免疫治疗中的双刃剑。
MedComm (2020). 2025 Feb 17;6(3):e70095. doi: 10.1002/mco2.70095. eCollection 2025 Mar.
5
Tumor cell membrane-based vaccines: A potential boost for cancer immunotherapy.基于肿瘤细胞膜的疫苗:癌症免疫疗法的潜在助力。
Exploration (Beijing). 2024 Mar 28;4(6):20230171. doi: 10.1002/EXP.20230171. eCollection 2024 Dec.
6
A Targeted and Protease-Activated Genetically Encoded Melittin-Containing Particle for the Treatment of Cutaneous and Visceral Leishmaniasis.一种靶向且具有蛋白酶激活特性的基因编码含蜂毒素粒子,用于治疗皮肤和内脏利什曼病。
ACS Appl Mater Interfaces. 2024 Sep 18;16(37):49148-49163. doi: 10.1021/acsami.4c10426. Epub 2024 Sep 6.
7
Dendritic Cell-Hitchhiking In Vivo for Vaccine Delivery to Lymph Nodes.树突细胞搭乘体内“便车”将疫苗递送至淋巴结。
Adv Sci (Weinh). 2024 Sep;11(33):e2402199. doi: 10.1002/advs.202402199. Epub 2024 Jul 4.
8
Programmable melanoma-targeted radio-immunotherapy via fusogenic liposomes functionalized with multivariate-gated aptamer assemblies.通过多功能门控适体组装体功能化的融合脂质体实现可编程的黑色素瘤靶向放射免疫治疗。
Nat Commun. 2024 Jun 12;15(1):5035. doi: 10.1038/s41467-024-49482-9.
9
Research progress on hydrogel-based drug therapy in melanoma immunotherapy.基于水凝胶的药物治疗在黑色素瘤免疫治疗中的研究进展。
BMB Rep. 2024 Feb;57(2):71-78. doi: 10.5483/BMBRep.2023-0160.
10
Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies.基于蜂毒素的纳米粒在抗肿瘤治疗中的最新进展:从作用机制到靶向递药策略。
J Nanobiotechnology. 2023 Nov 28;21(1):454. doi: 10.1186/s12951-023-02223-4.
细胞外囊泡在肺癌中的免疫调节作用及其相关治疗应用。
Front Immunol. 2020 Aug 28;11:2024. doi: 10.3389/fimmu.2020.02024. eCollection 2020.
4
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8 T cell exhaustion.胶原通过 LAIR1 依赖性 CD8 T 细胞耗竭促进癌症对 PD-1/PD-L1 的耐药性。
Nat Commun. 2020 Sep 9;11(1):4520. doi: 10.1038/s41467-020-18298-8.
5
Injectable Anti-inflammatory Nanofiber Hydrogel to Achieve Systemic Immunotherapy Post Local Administration.可注射抗炎纳米纤维水凝胶实现局部给药后的系统免疫治疗。
Nano Lett. 2020 Sep 9;20(9):6763-6773. doi: 10.1021/acs.nanolett.0c02684. Epub 2020 Aug 11.
6
Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines.解析次氯酸处理的抗原在基于抗癌树突状细胞的疫苗中免疫原性增强的机制
Vaccines (Basel). 2020 Jun 2;8(2):271. doi: 10.3390/vaccines8020271.
7
Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment.利用纳米医学克服免疫抑制性肿瘤微环境。
Acta Pharmacol Sin. 2020 Jul;41(7):970-985. doi: 10.1038/s41401-020-0424-4. Epub 2020 May 18.
8
Irradiated tumor cell-derived microparticles mediate tumor eradication via cell killing and immune reprogramming.辐照肿瘤细胞衍生的微粒通过细胞杀伤和免疫重编程来介导肿瘤清除。
Sci Adv. 2020 Mar 25;6(13):eaay9789. doi: 10.1126/sciadv.aay9789. eCollection 2020 Mar.
9
Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.靶向 CAMKII 重塑肿瘤相关巨噬细胞并抑制肿瘤细胞的可注射杂合肽水凝胶用于癌症免疫治疗。
Theranostics. 2020 Feb 10;10(7):3049-3063. doi: 10.7150/thno.42385. eCollection 2020.
10
Macrophages reprogrammed by lung cancer microparticles promote tumor development via release of IL-1β.肺癌微颗粒重编程的巨噬细胞通过释放白细胞介素-1β促进肿瘤发展。
Cell Mol Immunol. 2020 Dec;17(12):1233-1244. doi: 10.1038/s41423-019-0313-2. Epub 2019 Oct 24.